SRRK Latest Press Releases

-- October 20, 2026 --

Scholar Rock to Report Third Quarter 2026 Financial Results on November 10, 2026 Business Wire 8:00 AM

-- October 16, 2026 --

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:15 PM

-- October 8, 2026 --

Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (MAA) to European Medicines Agency (EMA) for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA) Business Wire 8:00 AM

-- September 30, 2026 --

Kuehn Law Encourages Investors of Scholar Rock Holding Corp to Contact Law Firm PRNewswire 9:56 AM

-- September 21, 2026 --

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 12:00 PM

-- September 11, 2026 --

Scholar Rock Announces FDA Approval of ISEMBYLD (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA) Business Wire 6:25 PM

-- September 2, 2026 --

Scholar Rock Receives FDA Fast Track Designation for Apitegromab Facioscapulohumeral Muscular Dystrophy (FSHD) Program as Participant Dosing Commences in Phase 2 FORGE Trial Business Wire 8:00 AM

-- August 27, 2026 --

Scholar Rock to Present at Upcoming Investor Conferences Business Wire 8:00 AM

-- August 21, 2026 --

Scholar Rock Provides Update on Global Apitegromab Regulatory Progress Across U.S., Europe, and Japan Business Wire 9:06 AM

-- August 14, 2026 --

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:15 PM

-- August 7, 2026 --

Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date Business Wire 4:20 PM

-- August 6, 2026 --

Scholar Rock Reports Second Quarter 2026 Financial Results and Recent Business Highlights Business Wire 7:00 AM

-- July 29, 2026 --

Scholar Rock to Present at the Canaccord Genuity 46th Annual Growth Conference Business Wire 8:00 AM

-- July 28, 2026 --

Kuehn Law Encourages Investors of Scholar Rock Holding Corp to Contact Law Firm PRNewswire 7:14 PM

-- July 20, 2026 --

Kuehn Law Encourages Investors of Scholar Rock Holding Corp to Contact Law Firm Globe Newswire 4:11 PM

Scholar Rock Provides Update on Timing of Committee for Medicinal Products for Human Use (CHMP) Opinion for Apitegromab Marketing Authorisation Application (MAA) for Spinal Muscular Atrophy (SMA) Business Wire 8:00 AM

-- July 17, 2026 --

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:15 PM

-- July 16, 2026 --

Scholar Rock to Report Second Quarter 2026 Financial Results on August 6, 2026 Business Wire 8:00 AM

-- June 22, 2026 --

Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD Business Wire 8:00 AM

-- June 12, 2026 --

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:15 PM

-- May 26, 2026 --

Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference Business Wire 9:30 AM

Market Data Delayed 15 Minutes